Literature DB >> 9694684

Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose.

R M Bieganski1, A Fowler, J R Morgan, M Toner.   

Abstract

The disaccharide trehalose is found to be effective for stabilization of active recombinant retroviruses in an amorphous dry state achieved through ambient-temperature vacuum dehydration of retroviral supernatants. Studies revealed that trehalose is a significantly better desiccation protectant than sucrose, glucose, and dextran: dextran has essentially no protective effect on retroviral survival after drying and rehydration. X-ray diffractometry of the retroviral supernatant dried with trehalose demonstrated its amorphous nature. The ability to dehydrate retroviral stocks at ambient temperatures into a stable glassy state will have a profound effect for researchers and commercial biotechnology companies which supply retroviral vectors for human gene therapy and basic research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694684     DOI: 10.1021/bp980057d

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  12 in total

1.  Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

Authors:  Yongsheng Ma; Jennifer C Pacan; Qi Wang; Yongping Xu; Xiaoqing Huang; Anton Korenevsky; Parviz M Sabour
Journal:  Appl Environ Microbiol       Date:  2008-05-30       Impact factor: 4.792

2.  Advancing microwave technology for dehydration processing of biologics.

Authors:  Stephanie L Cellemme; Matthew Van Vorst; Elisha Paramore; Gloria D Elliott
Journal:  Biopreserv Biobank       Date:  2013-10       Impact factor: 2.300

3.  Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

4.  Formulation of novel nano-encapsulated Newcastle disease vaccine tablets for vaccination of village chickens.

Authors:  Philemon N Wambura
Journal:  Trop Anim Health Prod       Date:  2010-08-04       Impact factor: 1.559

5.  Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.

Authors:  Leonard Y Chu; Ling Ye; Ke Dong; Richard W Compans; Chinglai Yang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2015-12-01       Impact factor: 4.200

6.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

Review 7.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Dynamics of C-phycocyanin in various deuterated trehalose/water environments measured by quasielastic and elastic neutron scattering.

Authors:  Ingo Köper; Sophie Combet; Winfried Petry; Marie-Claire Bellissent-Funel
Journal:  Eur Biophys J       Date:  2008-01-08       Impact factor: 1.733

9.  Development of thermostable lyophilized inactivated polio vaccine.

Authors:  Heleen Kraan; Paul van Herpen; Gideon Kersten; Jean-Pierre Amorij
Journal:  Pharm Res       Date:  2014-04-24       Impact factor: 4.200

10.  Coated microneedle arrays for transcutaneous delivery of live virus vaccines.

Authors:  Anto Vrdoljak; Marie G McGrath; John B Carey; Simon J Draper; Adrian V S Hill; Conor O'Mahony; Abina M Crean; Anne C Moore
Journal:  J Control Release       Date:  2011-12-29       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.